Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ADAMTS7 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | TMEM134 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
mRNA | EVI2B | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
mRNA | OR2C3 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
mRNA | ARV1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
mRNA | GGT1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
mRNA | INSR | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | NIPA2 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
mRNA | ZNF565 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | EXOC3L2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |